Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jonas Feilchenfeld"'
Autor:
Alexander R. Siebenhüner, Heike Seifert, Helga Bachmann, Burkhardt Seifert, Thomas Winder, Jonas Feilchenfeldt, Stefan Breitenstein, Pierre-Alain Clavien, Roger Stupp, Alexander Knuth, Bernhard Pestalozzi, Panagiotis Samaras
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Biliary tract cancer (BTC) is a dismal disease, even after curative intent surgery. We conducted this prospective, non-randomized phase II study to evaluate the feasibility and efficacy of cisplatin and gemcitabine as adjuvant tre
Externí odkaz:
https://doaj.org/article/5d29d9c60cc24dc8be376eb4754c2f55
Autor:
Dieter Koeberle, Piercarlo Saletti, Markus Peck-Radosavljevic, Panagiotis Samaras, Anna Dorothea Wagner, György Bodoky, Jean-François Dufour, Britta Tschanz, Michael Montemurro, Gabor Lakatos, Michael Buehlmann, Arnaud Roth, Qiyu Li, Jonas Feilchenfeld, Ivana Cvijetic, Daniel Rauch, Gyula Demeter, Karin Ribi, Daniel Horber
Publikováno v:
Journal of Clinical Oncology. 32:4099-4099
4099 Background: Sorafenib (S), a multitargeted tyrosine kinase inhibitor, has become standard of care for first-line systemic treatment of advanced HCC. Everolimus (E) is a potent inhibitor of the...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ced62b637ba59612775b98b6d793da7
https://doi.org/10.1200/jco.2014.32.15_suppl.4099
https://doi.org/10.1200/jco.2014.32.15_suppl.4099